Reading, United Kingdom

Naziha Alem




Average Co-Inventor Count = 16.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2018-2022

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Naziha Alem

Introduction

Naziha Alem is a prominent inventor based in Reading, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors of ATR protein kinase. With a total of three patents to her name, her work is paving the way for advancements in medical treatments.

Latest Patents

Naziha Alem's latest patents focus on compounds that are useful as inhibitors of ATR kinase. These inventions relate to pharmaceutically acceptable compositions that comprise the compounds, methods for treating various diseases, disorders, and conditions, as well as processes for preparing these compounds. The compounds are defined by specific formulas, I-A or I-B, where the variables are detailed in the patent documentation. This innovative work has the potential to impact the treatment landscape for numerous health conditions.

Career Highlights

Naziha Alem is currently employed at Vertex Pharmaceuticals, Inc., where she continues to push the boundaries of pharmaceutical research. Her expertise and dedication to innovation have established her as a key figure in her field.

Collaborations

Some of her notable coworkers include Jean-Damien Charrier and Christopher John Davis. Their collaborative efforts contribute to the dynamic research environment at Vertex Pharmaceuticals, Inc.

Conclusion

Naziha Alem's contributions to the field of pharmaceuticals through her innovative patents highlight her role as a leading inventor. Her work not only advances scientific knowledge but also holds promise for improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…